Doç. Dr. Demircan ÖZBALCI

Yayın Ağı

Makaleler 12

1. Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review

ÖZMEN İBİŞ D., Kürekçi D. D., ÖZKOCAMAN V., Altındağ Avcı B., Bozer D. S., Kasar M., et al.

Leukemia Research , cilt.166, 2026 (SCI-Expanded, Scopus)

2. Development of a machine learning-based risk warning model for potentially inappropriate medication use among older patients in a hematology service

ALBAYRAK A., Tokgöz B. F. D., ÖZBALCI D.

Journal of Oncology Pharmacy Practice , 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project

PINAR İ. E., Celik S., Polat M. G., Karatas A. F., Doğan A., ILTAR U., et al.

BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

4. East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients

Karacaoglu P. K., Asma S., Korur A., Solmaz S., Buyukkurt N. T., Gereklioglu C., et al.

Annals of Hematology , cilt.95, sa.6, ss.993-1000, 2016 (SCI-Expanded, Scopus)

5. Peripheral FLT-3 ligand levels as a pathobiological parameter during the clinical course of acute myeloid leukemia

Şahin M., HAZNEDAROĞLU İ. C., Özbalci D.

Turkish Journal of Medical Sciences , cilt.46, sa.6, ss.1889-1893, 2016 (SCI-Expanded, Scopus, TRDizin)

6. Successful management of imatinib despite alopecia and nail necrosis

Ergene U., Ozbalci D.

Transfusion and Apheresis Science , cilt.48, sa.2, ss.271-272, 2013 (SCI-Expanded, Scopus)

7. Disseminated Aspergillosis due to Aspergillus niger in Immunocompetent Patient: A Case Report.

Ergene U., Akcali Z., Ozbalci D., Nese N., Senol S.

Case reports in infectious diseases , cilt.2013, ss.385190, 2013 (Hakemli Dergi)

8. Hairy Cell Leukemia and cutaneous involvement

Ergene Ü., Özbalci D., Işisaĝ A.

Transfusion and Apheresis Science , cilt.46, sa.2, ss.231-232, 2012 (SCI-Expanded, Scopus)

9. H1N1 as a causative agent in febrile neutropenia of an acute myeloid leukaemia (AML) patient

Ergene U., Ozbalci D., Tunger O.

Transfusion and Apheresis Science , cilt.46, sa.1, ss.65-66, 2012 (SCI-Expanded, Scopus)

10. Brucellosis: A rare cause of febrile neutropenia in acute myeloblastic leukemia

Ozbalci D., Ergene U., Cetin C. B.

Medical Oncology , cilt.28, sa.1, ss.255-257, 2011 (SCI-Expanded, Scopus)

11. Aplastic anemia, mucormycosis and aspergillosis in infectious mononucleosis: Success is possible

Ergene U., ÖZBALCI D., BAYKAL B., Metin Ciris I., Yariktas M.

Transfusion and Apheresis Science , cilt.37, sa.2, ss.125-129, 2007 (SCI-Expanded, Scopus)

12. An unusual side-effect of tramadol: subcutaneous nodules

Coskun H. S., Ozbalci D., Sahin M.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.20, sa.8, ss.1008-1009, 2006 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Sjögren Sendromu, Ülseratif Kolit ve Hepatit B taşıyıcısı olan bir hastada lenfoma gelişimi: Olgu sunumu

KUTLU Ö. T., ÖZBALCI D., ALANOĞLU E. G.

43. Ulusal hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017, ss.157, (Özet Bildiri) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler